ARS Pharmaceuticals Inc. (SPRY) NASDAQ
$8.47 0.03 (0.36%)
Market Cap: $817.37M
As of 04/19/24 04:00 PM EDT. Market closed.
ARS Pharmaceuticals Inc. (SPRY)
NASDAQ
$8.47
0.03 (0.36%)
Market Cap: $817.37M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by ... read more
silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
20
Address
.
PRICE CHART FOR ARS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.39
Previous Close
$8.44
Days Range
$8.26 - $8.65
52 week range
$2.55 - $11.27
Volume
487,875
Avg. Volume (30 days)
759,993
Market Cap
$817.37M
Dividend Yield
-
P/E
(15.03)
Shares Outstanding
96,501,554
Open
$8.39
Previous Close
$8.44
Days Range
$8.26 - $8.65
52 week range
$2.55 - $11.27
Volume
487,875
Avg. Volume (30 days)
759,993
Market Cap
$817.37M
Dividend Yield
-
P/E
(15.03)
Shares Outstanding
96,501,554
FINANCIAL STATEMENTS FOR ARS PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ARS PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Apr 16, 2024 | Sale | $9.28 | 50,000 | 463,985 | 1,848,499 | Apr 17, 2024, 06:42 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Apr 16, 2024 | Sale | $9.28 | 50,000 | 464,020 | 1,647,447 | Apr 17, 2024, 06:42 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Apr 16, 2024 | Sale | $9.28 | 50,000 | 463,985 | 1,848,499 | Apr 17, 2024, 06:40 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Apr 16, 2024 | Sale | $9.28 | 50,000 | 464,020 | 1,647,447 | Apr 17, 2024, 06:40 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Apr 09, 2024 | Sale | $9.28 | 50,000 | 463,850 | 1,898,499 | Apr 10, 2024, 05:39 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Apr 09, 2024 | Sale | $9.28 | 50,000 | 463,885 | 1,646,494 | Apr 10, 2024, 05:39 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Apr 09, 2024 | Sale | $9.28 | 50,000 | 463,850 | 1,898,499 | Apr 10, 2024, 05:36 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Apr 09, 2024 | Sale | $9.28 | 50,000 | 463,885 | 1,646,494 | Apr 10, 2024, 05:36 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 25, 2024 | Buy | $9.06 | 437,600 | 3,964,656 | 8,994,374 | Mar 27, 2024, 07:37 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 27, 2024 | Buy | $9.79 | 505,954 | 4,953,290 | 9,958,073 | Mar 27, 2024, 07:37 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 26, 2024 | Buy | $9.55 | 457,745 | 4,371,465 | 9,452,119 | Mar 27, 2024, 07:37 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 25, 2024 | Sale | $9.12 | 47,632 | 434,575 | 1,948,499 | Mar 26, 2024, 06:48 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 25, 2024 | Sale | $9.12 | 47,635 | 434,612 | 1,697,447 | Mar 26, 2024, 06:48 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 22, 2024 | Sale | $9.01 | 1,326 | 11,952 | 1,996,131 | Mar 26, 2024, 06:48 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 22, 2024 | Sale | $9.03 | 1,017 | 9,183 | 1,745,082 | Mar 26, 2024, 06:48 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 22, 2024 | Sale | $9.01 | 1,326 | 11,952 | 1,996,131 | Mar 26, 2024, 06:47 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 22, 2024 | Sale | $9.03 | 1,017 | 9,183 | 1,745,082 | Mar 26, 2024, 06:47 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 25, 2024 | Sale | $9.12 | 47,632 | 434,575 | 1,948,499 | Mar 26, 2024, 06:47 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 25, 2024 | Sale | $9.12 | 47,635 | 434,612 | 1,697,447 | Mar 26, 2024, 06:47 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 21, 2024 | Sale | $9.00 | 100 | 900 | 1,997,457 | Mar 21, 2024, 09:51 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 21, 2024 | Sale | $9.00 | 372 | 3,348 | 1,746,099 | Mar 21, 2024, 09:51 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 19, 2024 | Sale | $9.04 | 942 | 8,513 | 1,997,557 | Mar 21, 2024, 09:51 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 19, 2024 | Sale | $9.03 | 976 | 8,811 | 1,746,471 | Mar 21, 2024, 09:51 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 21, 2024 | Sale | $9.00 | 100 | 900 | 1,997,457 | Mar 21, 2024, 09:50 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 21, 2024 | Sale | $9.00 | 372 | 3,348 | 1,746,099 | Mar 21, 2024, 09:50 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 19, 2024 | Sale | $9.04 | 942 | 8,513 | 1,997,557 | Mar 21, 2024, 09:50 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 19, 2024 | Sale | $9.03 | 976 | 8,811 | 1,746,471 | Mar 21, 2024, 09:50 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 14, 2024 | Sale | $9.00 | 239 | 2,151 | 2,046,960 | Mar 15, 2024, 07:55 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 14, 2024 | Sale | $9.00 | 205 | 1,845 | 1,744,789 | Mar 15, 2024, 07:55 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 13, 2024 | Sale | $9.00 | 1,300 | 11,700 | 2,047,199 | Mar 15, 2024, 07:55 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 13, 2024 | Sale | $9.00 | 1,500 | 13,500 | 1,744,994 | Mar 15, 2024, 07:55 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 15, 2024 | Sale | $9.14 | 48,461 | 442,997 | 1,998,499 | Mar 15, 2024, 07:55 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Mar 15, 2024 | Sale | $9.14 | 48,295 | 441,489 | 1,696,494 | Mar 15, 2024, 07:55 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 14, 2024 | Sale | $9.00 | 205 | 1,845 | 1,744,789 | Mar 15, 2024, 07:52 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 13, 2024 | Sale | $9.00 | 1,300 | 11,700 | 2,047,199 | Mar 15, 2024, 07:52 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 13, 2024 | Sale | $9.00 | 1,500 | 13,500 | 1,744,994 | Mar 15, 2024, 07:52 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 15, 2024 | Sale | $9.14 | 48,461 | 442,997 | 1,998,499 | Mar 15, 2024, 07:52 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 15, 2024 | Sale | $9.14 | 48,295 | 441,489 | 1,696,494 | Mar 15, 2024, 07:52 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Mar 14, 2024 | Sale | $9.00 | 239 | 2,151 | 2,046,960 | Mar 15, 2024, 07:52 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 29, 2024 | Sale | $9.02 | 1,000 | 9,019 | 1,747,447 | Mar 01, 2024, 08:21 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 29, 2024 | Sale | $9.01 | 1,982 | 17,867 | 2,048,499 | Mar 01, 2024, 08:21 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 29, 2024 | Sale | $9.02 | 800 | 7,215 | 1,746,494 | Mar 01, 2024, 08:21 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 29, 2024 | Sale | $9.01 | 1,982 | 17,867 | 2,048,499 | Mar 01, 2024, 08:17 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 29, 2024 | Sale | $9.02 | 800 | 7,215 | 1,746,494 | Mar 01, 2024, 08:17 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 29, 2024 | Sale | $9.02 | 1,000 | 9,019 | 1,747,447 | Mar 01, 2024, 08:17 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 26, 2024 | Sale | $9.01 | 500 | 4,505 | 2,099,500 | Feb 28, 2024, 09:08 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 26, 2024 | Sale | $9.01 | 100 | 901 | 1,772,750 | Feb 28, 2024, 09:08 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 28, 2024 | Sale | $9.02 | 24,303 | 219,225 | 1,748,447 | Feb 28, 2024, 09:08 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 28, 2024 | Sale | $9.02 | 49,019 | 442,210 | 2,050,481 | Feb 28, 2024, 09:08 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 28, 2024 | Sale | $9.02 | 25,456 | 229,626 | 1,747,294 | Feb 28, 2024, 09:08 PM |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Feb 26, 2024 | Sale | $9.01 | 100 | 901 | 1,772,750 | Feb 28, 2024, 09:08 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 26, 2024 | Sale | $9.01 | 100 | 901 | 1,772,750 | Feb 28, 2024, 09:04 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 28, 2024 | Sale | $9.02 | 24,303 | 219,225 | 1,748,447 | Feb 28, 2024, 09:04 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 28, 2024 | Sale | $9.02 | 49,019 | 442,210 | 2,050,481 | Feb 28, 2024, 09:04 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 28, 2024 | Sale | $9.02 | 25,456 | 229,626 | 1,747,294 | Feb 28, 2024, 09:04 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 26, 2024 | Sale | $9.01 | 100 | 901 | 1,772,750 | Feb 28, 2024, 09:04 PM |
| Lowenthal Richard E | PRESIDENT AND CEO | Feb 26, 2024 | Sale | $9.01 | 500 | 4,505 | 2,099,500 | Feb 28, 2024, 09:04 PM |
| Fitzpatrick Alexander A | Chief Legal Officer | Sep 29, 2023 | Buy | $3.78 | 46,258 | 174,994 | 89,227 | Oct 02, 2023, 04:23 PM |
| Fitzpatrick Alexander A | Chief Legal Officer | Sep 28, 2023 | Buy | $3.62 | 40,000 | 144,960 | 42,969 | Oct 02, 2023, 04:23 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Sep 21, 2023 | Buy | $3.03 | 2,700,000 | 8,183,526 | 8,556,774 | Sep 25, 2023, 04:30 PM |
| Shawver Laura | Director | Sep 01, 2023 | Option Exercise | $1.27 | 100,000 | 127,000 | 310,346 | Sep 05, 2023, 08:04 PM |
| Shawver Laura | Director | Sep 01, 2023 | Sale | $7.71 | 100,000 | 770,520 | 210,346 | Sep 05, 2023, 08:04 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Aug 29, 2023 | Buy | $6.20 | 3,750,000 | 23,249,999 | 5,856,774 | Aug 31, 2023, 05:26 PM |
| ORBIMED ADVISORS LLC | Director | Aug 29, 2023 | Buy | $6.20 | 500,000 | 3,100,000 | 8,019,187 | Aug 31, 2023, 05:26 PM |
| Thompson Peter A. | Director | Aug 29, 2023 | Buy | $6.20 | 500,000 | 3,100,000 | 8,019,187 | Aug 31, 2023, 05:18 PM |
| Shawver Laura | Director | Aug 04, 2023 | Option Exercise | $1.27 | 18,897 | 23,999 | 229,243 | Aug 07, 2023, 05:05 PM |
| Shawver Laura | Director | Aug 03, 2023 | Option Exercise | $1.27 | 26,107 | 33,156 | 236,453 | Aug 07, 2023, 05:05 PM |
| Shawver Laura | Director | Aug 04, 2023 | Sale | $7.06 | 18,897 | 133,471 | 210,346 | Aug 07, 2023, 05:05 PM |
| Shawver Laura | Director | Aug 03, 2023 | Sale | $7.01 | 26,107 | 183,018 | 210,346 | Aug 07, 2023, 05:05 PM |
| Shawver Laura | Director | Aug 02, 2023 | Option Exercise | $1.27 | 36,281 | 46,077 | 246,627 | Aug 03, 2023, 06:03 PM |
| Shawver Laura | Director | Aug 01, 2023 | Option Exercise | $1.27 | 18,715 | 23,768 | 229,061 | Aug 03, 2023, 06:03 PM |
| Shawver Laura | Director | Aug 02, 2023 | Sale | $7.09 | 36,281 | 257,265 | 210,346 | Aug 03, 2023, 06:03 PM |
| Shawver Laura | Director | Aug 01, 2023 | Sale | $7.19 | 18,715 | 134,576 | 210,346 | Aug 03, 2023, 06:03 PM |
| Shawver Laura | Director | Jul 07, 2023 | Option Exercise | $1.27 | 8,858 | 11,250 | 219,204 | Jul 07, 2023, 08:16 PM |
| Shawver Laura | Director | Jul 07, 2023 | Sale | $6.36 | 8,858 | 56,372 | 210,346 | Jul 07, 2023, 08:16 PM |
| Shawver Laura | Director | Jul 06, 2023 | Option Exercise | $1.27 | 33,510 | 42,558 | 243,856 | Jul 06, 2023, 08:55 PM |
| Shawver Laura | Director | Jul 05, 2023 | Option Exercise | $1.27 | 31,112 | 39,512 | 241,458 | Jul 06, 2023, 08:55 PM |
| Shawver Laura | Director | Jul 03, 2023 | Option Exercise | $1.27 | 26,520 | 33,680 | 236,866 | Jul 06, 2023, 08:55 PM |
| Shawver Laura | Director | Jul 06, 2023 | Sale | $6.34 | 33,510 | 212,554 | 210,346 | Jul 06, 2023, 08:55 PM |
| Shawver Laura | Director | Jul 05, 2023 | Sale | $6.41 | 31,112 | 199,552 | 210,346 | Jul 06, 2023, 08:55 PM |
| Shawver Laura | Director | Jul 03, 2023 | Sale | $6.72 | 26,520 | 178,347 | 210,346 | Jul 06, 2023, 08:55 PM |
| Shawver Laura | Director | Jun 02, 2023 | Option Exercise | $1.27 | 26,941 | 34,215 | 237,287 | Jun 02, 2023, 07:48 PM |
| Shawver Laura | Director | Jun 01, 2023 | Option Exercise | $1.27 | 73,059 | 92,785 | 283,405 | Jun 02, 2023, 07:48 PM |
| Shawver Laura | Director | Jun 02, 2023 | Sale | $6.95 | 26,941 | 187,240 | 210,346 | Jun 02, 2023, 07:48 PM |
| Shawver Laura | Director | Jun 01, 2023 | Sale | $6.80 | 73,059 | 496,801 | 210,346 | Jun 02, 2023, 07:48 PM |
| Shawver Laura | Director | May 08, 2023 | Option Exercise | $1.27 | 57,100 | 72,517 | 267,446 | May 10, 2023, 04:53 PM |
| Shawver Laura | Director | May 09, 2023 | Option Exercise | $1.27 | 42,900 | 54,483 | 253,246 | May 10, 2023, 04:53 PM |
| Shawver Laura | Director | Nov 09, 2022 | Sale | $4.58 | 43,896 | 201,044 | 210,346 | May 10, 2023, 04:53 PM |
| Shawver Laura | Director | May 09, 2023 | Sale | $5.31 | 42,900 | 227,799 | 210,346 | May 10, 2023, 04:53 PM |
| Shawver Laura | Director | May 08, 2023 | Sale | $6.16 | 57,100 | 351,736 | 210,346 | May 10, 2023, 04:53 PM |
| Scott Kathleen D. | Chief Financial Officer | Nov 29, 2022 | Buy | $6.24 | 8,250 | 51,506 | 8,250 | Dec 01, 2022, 04:31 PM |
| Shawver Laura | Chief Executive Officer | Aug 05, 2022 | Option Exercise | $1.27 | 78,740 | 100,000 | 254,242 | Aug 09, 2022, 04:38 PM |
| ROOT JONATHAN D | Director | Nov 15, 2021 | Buy | $8.85 | 2,014 | 17,824 | 2,364 | Mar 18, 2022, 05:14 PM |
| ROOT JONATHAN D | Director | Mar 03, 2021 | Buy | $52.07 | 350 | 18,224 | 350 | Mar 18, 2022, 05:14 PM |
| Hawkinson Russ | Sr. Vice President of Finance | Dec 08, 2020 | Buy | $21.00 | 200 | 4,200 | 200 | Feb 24, 2022, 07:55 PM |
| Presidio Management Group XII, L.L.C. | 10% Owner | Dec 08, 2020 | Buy | $21.00 | 47,619 | 999,999 | 47,619 | Dec 08, 2020, 09:04 PM |
| CAPPS VICKIE L | Director | Dec 08, 2020 | Buy | $21.00 | 9,523 | 199,983 | 61,576 | Dec 08, 2020, 08:56 PM |
| Hawkinson Russ | Sr. Vice President of Finance | Dec 08, 2020 | Buy | $21.00 | 238 | 4,998 | 238 | Dec 08, 2020, 08:52 PM |
| Piazza Jonathan | Chief Financial Officer | Dec 08, 2020 | Buy | $21.00 | 11,904 | 249,984 | 11,904 | Dec 08, 2020, 08:50 PM |
| Schroeder Thilo | Director | Dec 08, 2020 | Buy | $21.00 | 238,096 | 5,000,016 | 238,096 | Dec 08, 2020, 08:48 PM |
| ROOT JONATHAN D | Director | Dec 08, 2020 | Buy | $21.00 | 95,238 | 1,999,998 | 95,238 | Dec 08, 2020, 08:46 PM |
| Thompson Peter A. | Director | Dec 08, 2020 | Buy | $21.00 | 952,377 | 19,999,917 | 952,377 | Dec 08, 2020, 08:43 PM |
| Thompson Peter A. | Director | Dec 08, 2020 | Buy | $21.00 | 238,100 | 5,000,100 | 507,423 | Dec 08, 2020, 08:43 PM |
| ORBIMED ADVISORS LLC | Director | Dec 08, 2020 | Buy | $21.00 | 952,377 | 19,999,917 | 952,377 | Dec 08, 2020, 08:41 PM |
| ORBIMED ADVISORS LLC | Director | Dec 08, 2020 | Buy | $21.00 | 238,100 | 5,000,100 | 507,423 | Dec 08, 2020, 08:41 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 04/16/2024 | 463,985 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 04/16/2024 | 464,020 |
| Lowenthal Richard E | PRESIDENT AND CEO | 04/16/2024 | 463,985 |
| Lowenthal Richard E | PRESIDENT AND CEO | 04/16/2024 | 464,020 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 04/09/2024 | 463,850 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 04/09/2024 | 463,885 |
| Lowenthal Richard E | PRESIDENT AND CEO | 04/09/2024 | 463,850 |
| Lowenthal Richard E | PRESIDENT AND CEO | 04/09/2024 | 463,885 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/25/2024 | 3,964,656 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/27/2024 | 4,953,290 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/26/2024 | 4,371,465 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/25/2024 | 434,575 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/25/2024 | 434,612 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/22/2024 | 11,952 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/22/2024 | 9,183 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/22/2024 | 11,952 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/22/2024 | 9,183 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/25/2024 | 434,575 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/25/2024 | 434,612 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/21/2024 | 900 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/21/2024 | 3,348 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/19/2024 | 8,513 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/19/2024 | 8,811 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/21/2024 | 900 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/21/2024 | 3,348 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/19/2024 | 8,513 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/19/2024 | 8,811 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/14/2024 | 2,151 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/14/2024 | 1,845 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/13/2024 | 11,700 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/13/2024 | 13,500 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/15/2024 | 442,997 |
| Lowenthal Richard E | PRESIDENT AND CEO | 03/15/2024 | 441,489 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/14/2024 | 1,845 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/13/2024 | 11,700 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/13/2024 | 13,500 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/15/2024 | 442,997 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/15/2024 | 441,489 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 03/14/2024 | 2,151 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/29/2024 | 9,019 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/29/2024 | 17,867 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/29/2024 | 7,215 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/29/2024 | 17,867 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/29/2024 | 7,215 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/29/2024 | 9,019 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/26/2024 | 4,505 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/26/2024 | 901 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/28/2024 | 219,225 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/28/2024 | 442,210 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/28/2024 | 229,626 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 02/26/2024 | 901 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/26/2024 | 901 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/28/2024 | 219,225 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/28/2024 | 442,210 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/28/2024 | 229,626 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/26/2024 | 901 |
| Lowenthal Richard E | PRESIDENT AND CEO | 02/26/2024 | 4,505 |
| Fitzpatrick Alexander A | Chief Legal Officer | 09/29/2023 | 174,994 |
| Fitzpatrick Alexander A | Chief Legal Officer | 09/28/2023 | 144,960 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 09/21/2023 | 8,183,526 |
| Shawver Laura | Director | 09/01/2023 | 127,000 |
| Shawver Laura | Director | 09/01/2023 | 770,520 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 08/29/2023 | 23,249,999 |
| ORBIMED ADVISORS LLC | Director | 08/29/2023 | 3,100,000 |
| Thompson Peter A. | Director | 08/29/2023 | 3,100,000 |
| Shawver Laura | Director | 08/04/2023 | 23,999 |
| Shawver Laura | Director | 08/03/2023 | 33,156 |
| Shawver Laura | Director | 08/04/2023 | 133,471 |
| Shawver Laura | Director | 08/03/2023 | 183,018 |
| Shawver Laura | Director | 08/02/2023 | 46,077 |
| Shawver Laura | Director | 08/01/2023 | 23,768 |
| Shawver Laura | Director | 08/02/2023 | 257,265 |
| Shawver Laura | Director | 08/01/2023 | 134,576 |
| Shawver Laura | Director | 07/07/2023 | 11,250 |
| Shawver Laura | Director | 07/07/2023 | 56,372 |
| Shawver Laura | Director | 07/06/2023 | 42,558 |
| Shawver Laura | Director | 07/05/2023 | 39,512 |
| Shawver Laura | Director | 07/03/2023 | 33,680 |
| Shawver Laura | Director | 07/06/2023 | 212,554 |
| Shawver Laura | Director | 07/05/2023 | 199,552 |
| Shawver Laura | Director | 07/03/2023 | 178,347 |
| Shawver Laura | Director | 06/02/2023 | 34,215 |
| Shawver Laura | Director | 06/01/2023 | 92,785 |
| Shawver Laura | Director | 06/02/2023 | 187,240 |
| Shawver Laura | Director | 06/01/2023 | 496,801 |
| Shawver Laura | Director | 05/08/2023 | 72,517 |
| Shawver Laura | Director | 05/09/2023 | 54,483 |
| Shawver Laura | Director | 11/09/2022 | 201,044 |
| Shawver Laura | Director | 05/09/2023 | 227,799 |
| Shawver Laura | Director | 05/08/2023 | 351,736 |
| Scott Kathleen D. | Chief Financial Officer | 11/29/2022 | 51,506 |
| Shawver Laura | Chief Executive Officer | 08/05/2022 | 100,000 |
| ROOT JONATHAN D | Director | 11/15/2021 | 17,824 |
| ROOT JONATHAN D | Director | 03/03/2021 | 18,224 |
| Hawkinson Russ | Sr. Vice President of Finance | 12/08/2020 | 4,200 |
| Presidio Management Group XII, L.L.C. | 10% Owner | 12/08/2020 | 999,999 |
| CAPPS VICKIE L | Director | 12/08/2020 | 199,983 |
| Hawkinson Russ | Sr. Vice President of Finance | 12/08/2020 | 4,998 |
| Piazza Jonathan | Chief Financial Officer | 12/08/2020 | 249,984 |
| Schroeder Thilo | Director | 12/08/2020 | 5,000,016 |
| ROOT JONATHAN D | Director | 12/08/2020 | 1,999,998 |
| Thompson Peter A. | Director | 12/08/2020 | 19,999,917 |
| Thompson Peter A. | Director | 12/08/2020 | 5,000,100 |
| ORBIMED ADVISORS LLC | Director | 12/08/2020 | 19,999,917 |
| ORBIMED ADVISORS LLC | Director | 12/08/2020 | 5,000,100 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ARS PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | 1.12% | No change | Other |
| RA CAPITAL MANAGEMENT, L.P. | 10,860,977 | 1.66% | 14.81% | Other |
| ORBIMED ADVISORS LLC | 9,240,887 | 1.01% | No change | Other |
| BLACKROCK INC. | 2,637,549 | 0.00037% | 2.76% | Other |
| BAKER BROS. ADVISORS LP | 2,006,451 | 0.13% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 864,869 | 0.0005% | 7.66% | Other |
| ROYCE & ASSOCIATES LP | 473,700 | 0.02% | 2.16% | Value |
| ALPS ADVISORS INC | 66,396 | 0.00286% | -5.82% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 52,000 | 0.00044% | -62.24% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 17,439 | 0.00018% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR ARS PHARMACEUTICALS INC
STOCK BUYBACKS FOR ARS PHARMACEUTICALS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.58%
1Q
06/30/2023
1.29%
2Q
03/31/2023
2.02%
3Q
BUYBACK ANNOUNCEMENT(S) FOR ARS PHARMACEUTICALS INC
LOADING...